PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING?

• Pedro Moura,
• Bárbara Marques,
• Carolina Afonso,
• Rita Gomes,
• Sara Duarte,
• José Pedro Carda,
• Catarina Geraldes Santos,
• Raquel Guilherme

Affiliations

Pedro Moura

1 CHUC, Hematologia, Coimbra, Portugal

Bárbara Marques

1 CHUC, Hematologia, Coimbra, Portugal

Carolina Afonso

1 CHUC, Hematologia, Coimbra, Portugal

Rita Gomes

1 CHUC, Hematologia, Coimbra, Portugal

Sara Duarte

1 CHUC, Hematologia, Coimbra, Portugal

José Pedro Carda

2 Hospital da Luz, Hematologia, Portugal

Catarina Geraldes Santos

1 CHUC, Hematologia, Coimbra, Portugal

Raquel Guilherme

1 CHUC, Hematologia, Coimbra, Portugal